Evidence map›Paper›PMID 39364011›Full record

ArticleFrontiers in digital health2024

Scaling up! Staff e-learning for a national take-home naloxone program.

Øystein Bruun Ericson, Desiree Eide, Håvar Brendryen, Philipp Lobmaier, Thomas Clausen

Abstract read
In one paragraph

Article in Frontiers in digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Øystein Bruun EricsonNorwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Ullevål Hospital, Oslo, Norway.
Desiree EideNorwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Ullevål Hospital, Oslo, Norway.
Håvar BrendryenDepartment of Psychology, Faculty of Social Sciences, University of Oslo, Oslo, Norway.
Philipp LobmaierNorwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Ullevål Hospital, Oslo, Norway.
Thomas ClausenNorwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Ullevål Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A staff e-learning course was developed to prepare for scaling up a national take-home naloxone (THN) program in Norway. The aims of the study were to (a) describe participant characteristics for those that completed a THN e-learning course, (b) compare opioid overdose knowledge scores before and after e-learning course completion, and (c) to explore subsequent THN distribution by those trained. Methods: This was a quasi-experimental pre-test, post-test longitudinal cohort study of individuals completing a THN e-learning course from April 2021 to May 2022. Frequency analyses were performed for participant characteristics and subsequent naloxone distributions at 1-week and 1-month follow-up. The opioid overdose knowledge scale (OOKS) was used to measure pre-test-post-test knowledge among participants. Wilcoxon signed-rank test was performed for comparison between pre-test and post-test. Effect size was calculated using Cohen criteria. Results: In total, 371 individuals were included in this study. Most were either nurses or social workers ( Conclusions: Our findings suggest that an e-learning course is equally effective in terms of knowledge transfer as an in-person classroom setting, and may provide engagement in terms of naloxone distribution. However, our findings also emphasize the importance of clear implementation routines, including support from central coordinators to optimize the implementation process.

Indexed as

e-healthoverdose preventionpublic healthscaling upstaff training

Identifiers

PMID39364011
PMCPMC11448357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.